Literature DB >> 27775693

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

J Gauthier1,2,3, L Holmberg1,4, D Wu5, W Bensinger1,4, A K Gopal1,4, O Press1,4, D Maloney1,4, D J Green1,4, B G Till1,4, D Byelykh6, A Shustov1,6.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27775693     DOI： 10.1038/bmt.2016.227

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  19 in total

1.  Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.

Authors:  W Krüger; N Kröger; F Tögel; A Badbaran; H Renges; F Gieseking; K Gutensohn; F Jänicke; A R Zander
Journal:  J Hematother Stem Cell Res       Date:  2001-04

2.  9-color and 10-color flow cytometry in the clinical laboratory.

Authors:  Brent Wood
Journal:  Arch Pathol Lab Med       Date:  2006-05       Impact factor: 5.534

3.  High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

Authors:  David Wu; Anna Sherwood; Jonathan R Fromm; Stuart S Winter; Kimberly P Dunsmore; Mignon L Loh; Harvey A Greisman; Daniel E Sabath; Brent L Wood; Harlan Robins
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

4.  In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation.

Authors:  Andrei Shustov; Sindhu Cherian; Allison Shaw; Toni-Ann Lupinacci; David Maloney; Leona Holmberg; Ajay K Gopal
Journal:  Br J Haematol       Date:  2011-04-13       Impact factor: 6.998

5.  Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Authors:  Prashant Tembhare; Constance M Yuan; Liqiang Xi; John C Morris; David Liewehr; David Venzon; John E Janik; Mark Raffeld; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2011-06       Impact factor: 2.493

6.  Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.

Authors:  A Melnyk; A Rodriguez; W C Pugh; F Cabannillas
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

Review 7.  How I treat the peripheral T-cell lymphomas.

Authors:  Alison J Moskowitz; Matthew A Lunning; Steven M Horwitz
Journal:  Blood       Date:  2014-03-10       Impact factor: 22.113

Review 8.  Bone marrow histopathology in peripheral T-cell lymphomas.

Authors:  Ahmet Dogan; William G Morice
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 9.  The risk of tumor cell contamination in peripheral blood stem cell collections.

Authors:  T J Moss; A A Ross
Journal:  J Hematother       Date:  1992

10.  Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

Authors:  C Gisselbrecht; P Gaulard; E Lepage; B Coiffier; J Brière; C Haioun; D Cazals-Hatem; A Bosly; L Xerri; H Tilly; F Berger; R Bouhabdallah; J Diebold
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113
View more
  1 in total

Review 1.  Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.

Authors:  Andrew M Rogers; Jonathan E Brammer
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.